Emerging Treatments for Choroidal Metastases

Survey of Ophthalmology

Volumn 56, Issue 6, 2011, Pages 511-521

  Chen, Connie J ^a   McCoy, Allison N ^a   Brahmer, Julie ^b   Handa, James T ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choroidal metastases; Ocular metastases; Targeted therapy

Indexed keywords

ANASTROZOLE; BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; EXEMESTANE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; LETROZOLE; METHOTREXATE; PANITUMUMAB; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; SURFACTANT PROTEIN A; TAMOXIFEN; THYROID TRANSCRIPTION FACTOR 1; TRASTUZUMAB; VINCRISTINE;

ACNE; ADULT; BLEEDING; BLURRED VISION; BRACHYTHERAPY; BRAIN METASTASIS; BREAST CANCER; CASE REPORT; CHOROID CANCER; CHOROIDAL METASTASIS; COLON CANCER; COLORECTAL CANCER; DIARRHEA; DRUG MECHANISM; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOPHTHALMITIS; ESOPHAGEAL ADENOCARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FLUSHING; FOLLICULITIS; GAMMA KNIFE RADIOSURGERY; GENE MUTATION; HEART DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOCULAR HEMORRHAGE; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON THERAPY; REVIEW; THROMBOEMBOLISM; UVEITIS; VISUAL ACUITY; VITREOUS FLOATERS; WOUND HEALING IMPAIRMENT;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; PROTEIN KINASE INHIBITORS; QUINAZOLINES; TAXOIDS; TUMOR MARKERS, BIOLOGICAL; VISUAL ACUITY;

EID: 82355164288     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2011.05.001     Document Type: Review

References (71)

1. Altekruse SF, etal. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD, National Cancer Institute.
2. Amer R., et al. Treatment options in the management of choroidal metastases. Ophthalmologica 2004, 218(6):372-377.
3. Amselem L., Cervera E., Diaz-Llopis M., et al. Intravitreal bevacizumab (avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up. Eye (Lond) 2007, 21(4):566-567.
4. Battikh M.H., Ben Yahia S., Ben Sayah M.M., et al. Choroid metastases revealing pulmonary adenocarcioma resolved with chemotherapy [abstract only]. Rev Pneumol Clin 2004, 60(6 Pt 1):353-356.
5. Bellmann C., Fuss M., Holz F.G., et al. Stereotactic radiation therapy for malignant choroidal tumors: preliminary, short-term results. Ophthalmology 2000, 107(2):358-365.
6. Biswal B.M. Restoration of vision following combination chemotherapy of nasopharyngeal carcinoma choroidal metastases. Med Pediatr Oncol 2001, 37(5):484.
7. Bloch R.S., Gartner S. The incidence of ocular metastatic carcinoma. Arch Ophthalmol 1971, 85(6):673-675.
8. Brinkley J.R. Response of a choroidal metastasis to multiple-drug chemotherapy. Cancer 1980, 45(7):1538-1539.
9. Carlson R.W., Allred D.C., Anderson B.O., et al. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009, 7(2):122-192.
10. Chabner B.A., Roberts T.G. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 2005, 5(1):65-72.
11. Char D.H. Treatment of choroidal metastases. Arch Ophthalmol 1991, 109(3):333.
12. Ciardiello F., Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008, 358(11):1160-1174.
13. Daftari I.K., Petti P.L., Larson D.A., et al. A noninvasive eye fixation monitoring system for CyberKnife radiotherapy of choroidal and orbital tumors. Med Phys 2009, 36(3):719-724.
14. Eberhard D.A., Johnson B.E., Amler L.C., et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005, 23(25):5900-5909.
15. Engstrom P.F., Arnoletti J.P., Benson A.B., et al. NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 2009, 7(8):778-831.
16. Gazdar A.F. Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med 2009, 361(10):1018-1020.
17. George B., Wirostko W.J., Connor T.B., et al. Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. JThorac Oncol 2009, 4(5):661-662.
18. Gordon M.S., Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology 2005, 69(Suppl 3):25-33.
19. Gragoudas E.S., Goitein M., Verhey L., et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980, 87(6):571-581.
20. Gragoudas E.S., Goitein M., Koehler A.M., et al. Proton irradiation of small choroidal malignant melanomas. Am JOphthalmol 1977, 83(5):665-673.
21. Haas A., Pinter O., Papaefthymiou G., et al. Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology 2002, 109(5):909-913.
22. Harbour J.W. Photodynamic therapy for choroidal metastasis from carcinoid tumor. Am J Ophthalmol 2004, 137(6):1143-1145.
23. Hudis C.A. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med 2007, 357(1):39-51.
24. Imai K., Takaoka A. Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 2006, 6(9):714-727.
25. Isola V., Pece A., Pierro L. Photodynamic therapy with verteporfin of choroidal malignancy from breast cancer. Am J Ophthalmol 2006, 142(5):885-887.
26. Jost M., Kari C., Rodeck U. The EGF receptor-an essential regulator of multiple epidermal functions. Eur J Dermatol 2000, 10(7):505-510.
27. Kanthan G.L., Jayamohan J., Yip D., et al. Management of metastatic carcinoma of the uveal tract: an evidence-based analysis. Clin Experiment Ophthalmol 2007, 35(6):553-565.
28. Kerbel R.S. Tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049.
29. Kiratli H., Bilgic S. Transpupillary thermotherapy in the management of choroidal metastases. Eur J Ophthalmol 2004, 14(5):423-429.
30. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256(5517):495-497.
31. Kosmas C., Malamos N.A., Tsavaris N., et al. Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: A case report and literature review. JNeurooncol 2000, 47(2):161-165.
32. Kuo I.C., Haller J.A., Maffrand R., et al. Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment. Arch Ophthalmol 2008, 126(9):1311-1313.
33. Letson A.D., Davidorf F.H., Bruce R.A. Chemotherapy for treatment of choroidal metastases from breast carcinoma. Am J Ophthalmol 1982, 93(1):102-106.
34. Levinger S., Merin S., Seigal R., et al. Laser therapy in the management of choroidal breast tumor metastases. Ophthalmic Surg Lasers 2001, 32(4):294-299.
35. Lim J.I., Petrovich Z. Radioactive plaque therapy for metastatic choroidal carcinoma. Ophthalmology 2000, 107(10):1927-1931.
36. Lin C.J., Li K.H., Hwang J.F., et al. The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma-case report. Eye (Lond) 2010, 24(6):1102-1103.
37. Lindquist C. Gamma knife radiosurgery. Semin Radiat Oncol 1995, 5(3):197-202.
38. Logani S., Gomez H., Jampol L.M. Resolution of choroidal metastasis in breast cancer with high estrogen receptors. Arch Ophthalmol 1992, 110(4):451-452.
39. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl JMed 2004, 350(21):2129-2139.
40. Manquez M.E., Brown M.M., Shields C.L., et al. Management ofchoroidal metastases from breast carcinomas using aromatase inhibitors. Curr Opin Ophthalmol 2006, 17(3):251-256.
41. Maor M., Chan R.C., Young S.E. Radiotherapy of choroidal metastases: breast cancer as primary site. Cancer 1977, 40(5):2081-2086.
42. Marchini G., Babighian S., Tomazzoli L., et al. Gamma knife stereotactic radiosurgery of ocular metastases: a case report. Stereotact Funct Neurosurg 1995, 64(Suppl 1):67-71.
43. Mauget-Faysse M., Gambrelle J., Quaranta-El Maftouhi, et al. Photodynamic therapy for choroidal metastasis from lung adenocarcinoma. Acta Ophthalmol Scand 2006, 84(4):552-554.
44. Modorati G., Miserocchi E., Galli L., et al. Gamma knife radiosurgery for uveal melanoma: 12 years of experience. Br J Ophthalmol 2009, 93(1):40-44.
45. Morris P.G., Oda J., Heinemann M.H., et al. Choroidal metastases from esophageal adenocarcinoma responding to chemotherapy with cisplatin and irinotecan. J Clin Oncol 2010, 28(22):e372-e373.
46. Mueller A.J., Talies S., Schaller U.C., et al. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology 2000, 107(7):1381-1387. discussion 13878.
47. Munzone E., Nole F., Sanna G., et al. Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab. Breast 2005, 14(5):380-383.
48. Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancers from " never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004, 101(36):13306-13311.
49. Parsons J.T., Bova F.J., Fitzgerald C.R., et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994, 30(4):765-773.
50. Perls M. Beiträge zur geschwulstlehre [abstract only]. Virchows Archiv 1872, 1(4):437-467.
51. Robert C., Soria J.C., Spatz A., et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005, 6(7):491-500.
52. Rosset A., Zografos L., Coucke P., et al. Radiotherapy ofchoroidal metastases. Radiother Oncol 1998, 46(3):263-268.
53. Rudoler S.B., Corn B.W., Shields C.L., et al. External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys 1997, 38(2):251-256.
54. Rudoler S.B., Shields C.L., Corn B.W., et al. Functional vision isimproved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients. J Clin Oncol 1997, 15(3):1244-1251.
55. Saltz L.B., Clarke S., Diaz-Rubio E., et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008, 26(12):2013-2019.
56. Samuel J., Flood T.P., Agbemadzo B., et al. Choroidal metastasis from adenocarcinoma of the esophagus. Retina 2003, 23(6):874-877.
57. Seidman A., Hudis C., Pierri M.K., et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002, 20(5):1215-1221.
58. Shields C.L. Plaque radiotherapy for the management of uveal metastasis. Curr Opin Ophthalmol 1998, 9(3):31-37.
59. Shields C.L., Shields J.A., Gross N.E., et al. Survey of 520 eyes with uveal metastases. Ophthalmology 1997, 104(8):1265-1276.
60. Shields C.L., Shields J.A., De Potter P., et al. Plaque radiotherapy for the management of uveal metastasis. Arch Ophthalmol 1997, 115(2):203-209.
61. Shields C.L., Shields J.A., Cater J., et al. Plaque radiotherapy for uveal melanoma: Long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000, 118(9):1219-1228.
62. Shields C.L., Naseripour M., Cater J., et al. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Ophthalmology 2002, 109(10):1838-1849.
63. Soucek P., Cihelkova I. Photodynamic therapy with verteporfin in subfoveal choroidal metastasis of breast carcinoma (a controlled case). Neuro Endocrinol Lett 2006, 27(6):725-728.
64. Stephens R.F., Shields J.A. Diagnosis and management of cancer metastatic to the uvea: a study of 70 cases. Ophthalmology 1979, 86(7):1336-1349.
65. Tsina E.K., Lane A.M., Zacks D.N., et al. Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology 2005, 112(2):337-343.
66. Wharam M.D., Schachat A.P. Chapter 45: Choroidal metastasis. Retina 2006, 811-818. Elsevier Inc., Philadelphia. 4th ed. S.J. Ryan, A.P. Schachat, C.P. Wilkinson (Eds.).
67. Widakowich C., de Castro G., de Azambuja E., et al. Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist 2007, 12(12):1443-1455.
68. Wiegel T., Bottke D., Kreusel K.M., et al. External beam radiotherapy of choroidal metastases-final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol 2002, 64(1):13-18.
69. Wong Z.W., Phillips S.J., Ellis M.J. Dramatic response ofchoroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine. Breast J 2004, 10(1):54-56.
70. Yao H.Y., Horng C.T., Chen J.T., et al. Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab. Acta Ophthalmol 2010, 88(7):282-283.
71. Zorlu F., Selek U., Kiratli H. Initial results of fractionated CyberKnife radiosurgery for uveal melanoma. J Neurooncol 2009, 94(1):111-117.